Circulating TP53 mutations are predictive and prognostic biomarkers in pancreatic cancer patients treated with FOLFIRINOX chemotherapy
| Autor: | Van Der Sijde, F., Azmani, Z., Besselink, M., Bonsing, B., de Groot, J.W., Koerkamp, B. Groot, Haberkorn, B., Homs, M., van Ijcken, W., Janssen, Q., Lolkema, M., Luelmo, S., Mekenkamp, L., Mustafa, D., van Schaik, R., Wilmink, J., van Eijck, C., Vietsch, E. |
|---|---|
| Zdroj: | In Pancreatology July 2021 21 Supplement 1:S12-S13 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect